As of 2026-05-26, the Relative Valuation of Solasia Pharma KK (4597.T) is (110.11) JPY. This relative valuation is based on P/E multiples. With the latest stock price at 27.00 JPY, the upside of Solasia Pharma KK based on Relative Valuation is -507.8%.
The range of the Relative Valuation is (98.50) - (118.68) JPY.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 36.5x | 32.0x |
| Forward P/E multiples | 30.3x - 40.9x | 35.6x |
| Fair Price | (98.50) - (118.68) | (110.11) |
| Upside | -464.8% - -539.6% | -507.8% |
| Date | P/E |
| 2026-05-25 | -8.29 |
| 2026-05-22 | -7.99 |
| 2026-05-21 | -7.99 |
| 2026-05-20 | -7.68 |
| 2026-05-19 | -8.29 |
| 2026-05-18 | -8.60 |
| 2026-05-15 | -9.22 |
| 2026-05-14 | -9.22 |
| 2026-05-13 | -8.91 |
| 2026-05-12 | -9.22 |
| 2026-05-11 | -9.83 |
| 2026-05-08 | -9.83 |
| 2026-05-07 | -9.83 |
| 2026-05-01 | -9.83 |
| 2026-04-30 | -10.14 |
| 2026-04-28 | -10.44 |
| 2026-04-27 | -10.14 |
| 2026-04-24 | -10.75 |
| 2026-04-23 | -11.06 |
| 2026-04-22 | -11.37 |
| 2026-04-21 | -11.98 |
| 2026-04-20 | -12.60 |
| 2026-04-17 | -11.67 |
| 2026-04-16 | -11.06 |
| 2026-04-15 | -10.44 |
| 2026-04-14 | -10.44 |
| 2026-04-13 | -10.14 |
| 2026-04-10 | -10.44 |
| 2026-04-09 | -10.44 |
| 2026-04-08 | -10.75 |
| 2026-04-07 | -10.44 |
| 2026-04-06 | -10.44 |
| 2026-04-03 | -10.44 |
| 2026-04-02 | -11.37 |
| 2026-04-01 | -9.83 |
| 2026-03-31 | -9.52 |
| 2026-03-30 | -10.14 |
| 2026-03-27 | -10.14 |
| 2026-03-26 | -10.14 |
| 2026-03-25 | -9.52 |
| 2026-03-24 | -9.22 |
| 2026-03-23 | -8.91 |
| 2026-03-19 | -9.83 |
| 2026-03-18 | -9.83 |
| 2026-03-17 | -9.83 |
| 2026-03-16 | -9.83 |
| 2026-03-13 | -9.83 |
| 2026-03-12 | -9.83 |
| 2026-03-11 | -10.44 |
| 2026-03-10 | -10.14 |